Could DTC marketing be a bad thing for the consumer/ public at large? If products that can address mass diseases are mass marketed, diseases which cannot be marketed may end up not addressed by pharmaceutical companies.
I'm a big believer in self-regulation for markets. I believe that any industry well end up correcting itself. Much like the extra caution taken by lenders and borrowers today after our country's sub prime loan debacle, compared to the years it will take our government to impose regulations to prevent another high risk credit bomb like the one that exploded last year. But pharma seems different. We can't afford the time and health is far more than money. Not to be sappy, but we can always make more money...can't make more health if you loose it.
Will R&D on lesser prevalent diseases be nipped in the bud because they are not viable (profitable) on the mass scale? If so, should government intervene?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment